Chinese Vaccine Coronavac

Two doses of the China-made COVID-19 vaccine, CoronaVac, are safe and produce a strong antibody response among children and adolescents aged 3-17 years, according to a study published in The Lancet Infectious Diseases journal.

China has authorised the emergency use of CoronaVac, a COVID-19 vaccine manufactured by Chinese firm Sinovac, for children aged between 3 and 17 years, Sinovac Chairman Yin Weidong said.

Clinical trials of the CoronaVac coronavirus vaccine developed by Chinese laboratory Sinovac have "reached the efficacy threshold" demanded by the World Health Organization, the Brazilian institute charged with its production and distribution said on Wednesday.

Brazil's health regulator said Monday it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an "adverse incident" involving a volunteer recipient, a blow for one of the most advanced vaccine candidates.

Two doses of the China-made COVID-19 vaccine, CoronaVac, are safe and produce a strong antibody response among children and adolescents aged 3-17 years, according to a study published in The Lancet Infectious Diseases journal.

China has authorised the emergency use of CoronaVac, a COVID-19 vaccine manufactured by Chinese firm Sinovac, for children aged between 3 and 17 years, Sinovac Chairman Yin Weidong said.

Clinical trials of the CoronaVac coronavirus vaccine developed by Chinese laboratory Sinovac have "reached the efficacy threshold" demanded by the World Health Organization, the Brazilian institute charged with its production and distribution said on Wednesday.

Brazil's health regulator said Monday it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an "adverse incident" involving a volunteer recipient, a blow for one of the most advanced vaccine candidates.